Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026
2027
2028
2029
2030
Trend
ROE
-6.07%
-6.85%
-7.91%
-9.24%
-10.94%
-12.8%
Sector average
-19.57%
-18.86%
21.26%
45.9%
27.83%
13.61%
ROA
-2.68%
-2.71%
-2.82%
-2.92%
-3.03%
-3.09%
Sector average
-4.19%
-6.68%
-24.58%
1.77%
-29.44%
7.73%
Gross Margin
16.98%
16.98%
16.98%
16.98%
Amounts in CHF (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as â-â. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for PolyPeptide Group AG? It covers the balance sheet, income statement and Equlion model projections.
16.98%
16.98%
Sector average
40.44%
40.6%
40.6%
40.6%
40.6%
40.6%
Net Margin
-5.4%
-5.22%
-4.88%
-4.65%
-4.49%
-4.38%
Total Assets
CHFÂ 825,959.00K
CHFÂ 840,156.41K
CHFÂ 873,039.43K
CHFÂ 904,152.51K
CHFÂ 930,564.23K
CHFÂ 938,858.65K
Sector average
CHFÂ 6,583,664.69K
CHFÂ 7,029,775.91K
CHFÂ 7,875,113.17K
CHFÂ 8,842,325.96K
CHFÂ 9,880,548.85K
CHFÂ 10,888,357.41K
Net Income
-CHFÂ 21,169.00K
-CHFÂ 22,571.38K
-CHFÂ 24,185.57K
-CHFÂ 25,944.92K
-CHFÂ 27,788.99K
-CHFÂ 28,876.25K
Sector average
CHFÂ 509,037.80K
CHFÂ 497,738.03K
CHFÂ 567,206.48K
CHFÂ 655,953.18K
CHFÂ 738,044.20K
CHFÂ 795,142.15K
Valuation
CHFÂ 861,728.33K
CHFÂ 918,814.94K
CHFÂ 984,524.31K
CHFÂ 1,056,142.25K
CHFÂ 1,131,208.94K
CHFÂ 1,175,468.06K
Sector average
CHFÂ 12,182,569.70K
CHFÂ 13,169,956.24K
CHFÂ 13,319,586.58K
CHFÂ 13,502,659.68K
CHFÂ 13,728,881.51K
CHFÂ 13,908,079.25K
Stock Price
CHFÂ 26.10
CHFÂ 27.83
CHFÂ 29.82
CHFÂ 31.99
CHFÂ 34.26
CHFÂ 35.60
Sector average
CHFÂ 102.74
CHFÂ 98.77
CHFÂ 102.59
CHFÂ 107.21
CHFÂ 112.19
CHFÂ 115.32
PolyPeptide Group AG (PPGN.SW) Financial Forecast | Equlion
